{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:22:09Z","timestamp":1793654529242,"version":"4.5.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K05928"],"award-info":[{"award-number":["19K05928"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K18342"],"award-info":[{"award-number":["22K18342"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007451","name":"Cell Science Research Foundation","doi-asserted-by":"publisher","award":["JP24ae0121040"],"award-info":[{"award-number":["JP24ae0121040"]}],"id":[{"id":"10.13039\/100007451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20am0101086"],"award-info":[{"award-number":["JP20am0101086"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["1469"],"award-info":[{"award-number":["1469"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJFR2354"],"award-info":[{"award-number":["JPMJFR2354"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007325","name":"Kobayashi International Scholarship Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.stemcr.2026.102891","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:15:48Z","timestamp":1776352548000},"page":"102891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Organoid phenotypic screening identified glycyrrhizin that confers protection against tumor necrosis factor-induced cell death"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-2925","authenticated-orcid":false,"given":"Yu","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurina","family":"Koura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotatsu","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kurashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stemcr.2026.102891_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082244","article-title":"Anti-TNF Therapy in Crohn's Disease","volume":"19","author":"Adegbola","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.stemcr.2026.102891_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2036.2011.04612.x","article-title":"Review article: loss of response to anti-TNF treatments in Crohn's disease","volume":"33","author":"Ben-Horin","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.stemcr.2026.102891_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J. Pathol."},{"key":"10.1016\/j.stemcr.2026.102891_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.stemcr.2026.102891_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.immuni.2011.09.020","article-title":"RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome","volume":"35","author":"Duprez","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.stemcr.2026.102891_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0022-1759(84)90147-9","article-title":"Comparison of in vitro cell cytotoxic assays for tumor necrosis factor","volume":"68","author":"Flick","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.stemcr.2026.102891_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2012-1050","article-title":"11\u03b2-Hydroxysteroid Dehydrogenase 1: Translational and Therapeutic Aspects","volume":"34","author":"Gathercole","year":"2013","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.stemcr.2026.102891_bib8","series-title":"Sweeteners: Pharmacology, Biotechnology, and Applications","first-page":"245","article-title":"The Pharmacological Activities of Glycyrrhizinic Acid (\u201cGlycyrrhizin\u201d) and Glycyrrhetinic Acid","author":"Graebin","year":"2018"},{"key":"10.1016\/j.stemcr.2026.102891_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature10400","article-title":"Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis","volume":"477","author":"G\u00fcnther","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102891_bib10","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/gutjnl-2011-301364","article-title":"Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium","volume":"62","author":"G\u00fcnther","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.stemcr.2026.102891_bib11","doi-asserted-by":"crossref","first-page":"8436","DOI":"10.1074\/jbc.M116.769380","article-title":"Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity","volume":"292","author":"Horiuchi","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.stemcr.2026.102891_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abh1586","article-title":"The development of a functional human small intestinal epithelium model for drug absorption","volume":"7","author":"Kwon","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.stemcr.2026.102891_bib13","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1101\/gad.13.19.2514","article-title":"Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis","volume":"13","author":"Lin","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.stemcr.2026.102891_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2017.05.020","article-title":"Differentiation of Human Pluripotent Stem Cells into Colonic Organoids via Transient Activation of BMP Signaling","volume":"21","author":"M\u00fanera","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102891_bib15","first-page":"2350","article-title":"High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease","volume":"97","author":"Mart\u00ednez-Borra","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.stemcr.2026.102891_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.stemcr.2026.102891_bib17","first-page":"415","article-title":"Therapeutic effects of glycyrrhizic acid","volume":"8","author":"Ming","year":"2013","journal-title":"Nat. Prod. Commun."},{"key":"10.1016\/j.stemcr.2026.102891_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bjp.0703336","article-title":"Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury","volume":"130","author":"Mocanu","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.stemcr.2026.102891_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.chembiol.2007.03.007","article-title":"Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities","volume":"14","author":"Mollica","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.stemcr.2026.102891_bib20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","article-title":"IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting","volume":"16","author":"Moschen","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.stemcr.2026.102891_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10495-021-01663-3","article-title":"Release mechanisms of major DAMPs","volume":"26","author":"Murao","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.stemcr.2026.102891_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pharmthera.2013.11.001","article-title":"An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies","volume":"141","author":"Musumeci","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.stemcr.2026.102891_bib23","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.stemcr.2026.102891_bib24","doi-asserted-by":"crossref","first-page":"12414","DOI":"10.1002\/anie.201205576","article-title":"How thiostrepton was made in the laboratory","volume":"51","author":"Nicolaou","year":"2012","journal-title":"Angew. Chem."},{"key":"10.1016\/j.stemcr.2026.102891_bib25","first-page":"79","volume":"26","year":"2007","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.stemcr.2026.102891_bib26","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41575-020-0326-4","article-title":"Cell death in the gut epithelium and implications for chronic inflammation","volume":"17","author":"Patankar","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.stemcr.2026.102891_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nri3608","article-title":"Intestinal epithelial cells: regulators of barrier function and immune homeostasis","volume":"14","author":"Peterson","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.stemcr.2026.102891_bib28","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00774-012-0413-x","article-title":"Glycyrrhizic acid (GCA) as 11\u03b2-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis","volume":"31","author":"Ramli","year":"2013","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.stemcr.2026.102891_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn\u2019s disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.stemcr.2026.102891_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0300-9084(86)80177-8","article-title":"The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation","volume":"68","author":"Rousset","year":"1986","journal-title":"Biochimie"},{"key":"10.1016\/j.stemcr.2026.102891_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2019.01.047","article-title":"Glycyrrhizic acid as a multifunctional drug carrier - From physicochemical properties to biomedical applications: A modern insight on the ancient drug","volume":"559","author":"Selyutina","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.stemcr.2026.102891_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature09691","article-title":"Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro","volume":"470","author":"Spence","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.stemcr.2026.102891_bib33","doi-asserted-by":"crossref","first-page":"27084","DOI":"10.1074\/jbc.273.42.27084","article-title":"Pro-caspase-3 is a major physiologic target of caspase-8","volume":"273","author":"Stennicke","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.stemcr.2026.102891_bib34","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fimmu.2019.00939","article-title":"Dipotassium Glycyrrhizate Improves Intestinal Mucosal Healing by Modulating Extracellular Matrix Remodeling Genes and Restoring Epithelial Barrier Functions","volume":"10","author":"Stronati","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.stemcr.2026.102891_bib35","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1038\/s41598-023-32438-2","article-title":"Drug cytotoxicity screening using human intestinal organoids propagated with extensive cost-reduction strategies","volume":"13","author":"Takahashi","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.stemcr.2026.102891_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104542","article-title":"Organoid-derived intestinal epithelial cells are a suitable model for preclinical toxicology and pharmacokinetic studies","volume":"25","author":"Takahashi","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.stemcr.2026.102891_bib37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.stemcr.2017.11.004","article-title":"A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial Organoids","volume":"10","author":"Takahashi","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.stemcr.2026.102891_bib38","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.2042-7158.1996.tb05998.x","article-title":"Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis","volume":"48","author":"Takeda","year":"1996","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.stemcr.2026.102891_bib39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbrc.2019.01.136","article-title":"Papaverine identified as an inhibitor of high mobility group box 1\/receptor for advanced glycation end-products interaction suppresses high mobility group box 1-mediated inflammatory responses","volume":"511","author":"Tamada","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.stemcr.2026.102891_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1078\/0065-1281-00601","article-title":"The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition","volume":"103","author":"Van Noorden","year":"2001","journal-title":"Acta Histochem."},{"key":"10.1016\/j.stemcr.2026.102891_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.stem.2023.04.011","article-title":"Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation","volume":"30","author":"Vandana","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stemcr.2026.102891_bib42","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.187.9.1477","article-title":"Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor","volume":"187","author":"Vercammen","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.stemcr.2026.102891_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aab1201","article-title":"Developing predictive assays: the phenotypic screening rule of 3","volume":"7","author":"Vincent","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stemcr.2026.102891_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.274","article-title":"Organoids: The current status and biomedical applications","volume":"4","author":"Yang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.stemcr.2026.102891_bib45","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1158\/1535-7163.MCT-11-0185","article-title":"PF-04691502, a potent and selective oral inhibitor of PI3K and mTOR kinases with antitumor activity","volume":"10","author":"Yuan","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.stemcr.2026.102891_bib46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.stemcr.2026.102891_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.semcdb.2014.07.013","article-title":"Necroptosis in health and diseases","volume":"35","author":"Zhou","year":"2014","journal-title":"Semin. Cell Dev. Biol."}],"container-title":["Stem Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671126001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213671126001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:53:15Z","timestamp":1778763195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213671126001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2213671126001025"],"URL":"https:\/\/doi.org\/10.1016\/j.stemcr.2026.102891","relation":{},"ISSN":["2213-6711"],"issn-type":[{"value":"2213-6711","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organoid phenotypic screening identified glycyrrhizin that confers protection against tumor necrosis factor-induced cell death","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stemcr.2026.102891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society for Stem Cell Research.","name":"copyright","label":"Copyright"}],"article-number":"102891"}}